Description: A two-year study of 200 patients in 14 Canadian cities will examine the effectiveness of the oral acne drug minocycline in controlling multiple sclerosis (MS), the Toronto Star reported. The multi-center trial, announced Thursday, was organized after findings from earlier small studies suggested that minocycline helped patients with the neurodegenerative disease.